Almost half of LGBTQ youth seriously considered attempting suicide in the past year, according to survey results published Wednesday by The Trevor Project, an organization that runs crisis intervention and suicide prevention services for LGBTQ people under 25.
A speech on U.S.-China relations that Secretary of State Antony Blinken was set to give on Thursday will be rescheduled in light of Blinken's positive COVID-19 diagnosis, State Department spokesperson Ned Price said Wednesday.
Driving the news: Blinken, who is fully vaccinated and boosted against the virus, tested positive for COVID-19 earlier Wednesday, but is experiencing only "mild symptoms," Price said in a press release.
A Food and Drug Administration (FDA) official said Wednesday that there is "no evidence" that a second round of the Pfizer COVID pill Paxlovid will help patients who suffer a relapse in symptoms.
Why it matters: The FDA’s comments contradict Pfizer chief executive officer Albert Bourla, who said patients experiencing COVID-19 symptoms after their first treatment can take more of the pill.
Americans continue to wrongly blame people of Asian descent for the coronavirus, and a greater percentage are harboring distrust of their loyalties, according to a new report out this morning.
Executives at telehealth startup Cerebral told their clinicians that the company will stop prescribing Adderall and other controlled substances to treat attention deficit hyperactivity disorder, the company announced Wednesday.
Driving the news: The decision comes after Cerebral's preferred pharmacy, Truepill, said it would halt prescriptions for Adderall and other controlled substances, the Wall Street Journal reported last week.
During an Axios event Wednesday, Sen. Tom Carper (D-Del.) called on Congress to vote on COVID preparedness funding separately from measures on supporting Ukraine and a bill that would reimpose Title 42.
State of play: Republicans have held that they won't pass funding for COVID or Ukraine unless Congress brings back Title 42, which allows border authorities to turn away migrants attempting to enter the U.S. due to the pandemic emergency, NBC reports.
Biogen's decision Tuesday to replace its CEO and largely give up marketing the controversial Alzheimer's drug Aduhelm could refocus attention on drugs that target disease processes that contribute to Alzheimer's.
The big picture: Aduhelm's effective demise means we'll likely need multiple drugs and diagnostic tools to tailor combination treatments for individual patients, according to experts.
One in five parents of children under age 5 are ready to get their kids vaccinated as soon as COVID-19 shots are available for that age group while about twice as many parents are taking a wait-and-see approach, according to a Kaiser Family Foundation survey.
By the numbers: Though the FDA has still not authorized any COVID-19 vaccine for young children, 18% of parents of children under 5 said they'll vaccinate their kids right away once a shot is authorized.
The implications of Roe v. Wade being overturned could stretch far beyond accessing an abortion.
Why it matters: Patients experiencing early miscarriages, ectopic pregnancies, or life-threatening medical conditions could also lose access to timely care, experts said Tuesday.
The number of U.S. women who get abortions has decreased dramatically in recent decades, with typical patients now tendingto be in their 20s and living in blue states.
Why it matters: Abortion access is likely to be drastically curtailed in red states should a leaked draft of a U.S. Supreme Court decision hold, gutting the federal right to an abortion. But the profile of abortion patients has trended older since that right was established, and the vast majority of procedures tend to be early in pregnancies.